<DOC>
	<DOCNO>NCT02614768</DOCNO>
	<brief_summary>The purpose study assess accuracy reliability SPIDIMAN CGM sensor system regard value measure Super GL compare result similar evaluation Medtronic MiniMed 640G system , Abbott FreeStyle Libre Flash Sensor DexCom G4 Platinum Sensor patient type 1 Diabetes .</brief_summary>
	<brief_title>Standardized Evaluation Subcutaneous Glucose Monitoring Systems Under Routine Environmental Conditions</brief_title>
	<detailed_description>The study single-center open-label study patient type 1 diabetes treat continuous subcutaneous insulin infusion ( CSII ) multiple daily injection ( MDI ) therapy . The study include total 12 subject .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<criteria>Informed consent obtain advised nature study Male female age ≥18 year Type 1 diabetes least 6 month accord WHO definition Treatment multiple daily injection ( MDI ) continuous subcutaneous insulin infusion ( CSII ) least 3 month Body Mass Index ( BMI ) &lt; 35 kg/m² Willing able wear 5 CGM device duration study undergo study procedure . HbA1c ≤ 86 mmol/mol Any disease condition investigator treat physician feel would interfere trial safety subject Female childbearing potential pregnant , breastfeed intend become pregnant use adequate contraceptive method Any mental condition render subject incapable give consent Subject use medication significantly impact glucose metabolism ( oral steroid ) except stable least last three month expect remain stable study duration Subject may use acetaminophen ( paracetamol ) participate study Has severe medical psychological condition ( ) chronic conditions/infections opinion Investigator would compromise subject 's safety successful participation study . Subject actively enrol another clinical trial Known adrenal gland problem , pancreatic tumour , insulinoma Inability subject comply study procedure Inability subject understand patient information . Subject donate blood last 3 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Glucose Monitoring System</keyword>
</DOC>